Catalyst Crew Technologies Corp. (OTC: CCTC) provided an update on the development of its telehealth platform infrastructure, a key component of its digital health strategy for emerging markets. The platform is designed to support remote patient engagement, care coordination, and integration of artificial intelligence-driven analytics tools within a technology-enabled healthcare environment.
The platform will facilitate communication between patients, healthcare providers, and service participants while enabling structured data collection and workflow coordination across multiple points of care. It is intended to integrate with the company’s broader AI healthcare platform, including the CardioAI, PulmoAI, and NeuroAI modules, which are being developed for data-driven analytics and clinical decision-support capabilities.
Development efforts are focused on core platform functionality, including system architecture, data integration, user workflows, and operational processes. The company is evaluating approaches to ensure scalability, interoperability, and integration with existing healthcare systems and technologies.
Catalyst Crew is leveraging its wholly-owned subsidiary in Venezuela to support local platform development, operational coordination, and infrastructure planning. Initial efforts are concentrated in Venezuela, with potential expansion into other Latin American markets as development progresses. The company emphasized that the platform is intended to support healthcare providers and service participants and does not replace licensed medical professionals or clinical decision-making.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated: “We are focused on building a scalable and integrated telehealth platform that can support healthcare coordination and data-driven insights. Our approach is centered on developing infrastructure that can operate within real-world healthcare environments and support future expansion across Latin America.”
The company continues to advance its digital health and AI platform and evaluate opportunities for expansion across emerging markets. More information is available at https://catalystcrewai.com or in the company’s SEC filings at www.sec.gov.
